2Davis PJ, Ross AK, Stiller RL, et al. Pharmacokinetics of remifentanil in anesthetized children 2-12 years of age. Anesth Analg, 1995,80:S93.
3Burkle H, Dunbar S, Van Aken H. Remifentanil: a novel, short-acting,mu-opioid. Anesth Analg, 1996,83: 646-651.
4Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg, 1993,77:1031-1040.
5Ross AK, Davis PJ, Dear GDEL, et al. Pharmcokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesth Analg,2001,93:1393-1401.
6John BE, Anne ML. Use of remifentanil in infants. Paediatric Anaesthesia, 1998,8:437-439.
7Bovill JG, Sebel PS. Pharmacokinetics of high-dose fentanyl. A study in patients undergoing cardiac surgery. Br J Anaesth, 1980,52:795-801.
8Hug CC, Burm AGL, de Lange S. Alfentanil pharmacokinetics in cardiac surgical patients. Anesth Analg, 1994,78:231-239.
9Davis PJ, Wilson AS, Siewers RD, et al. The effects of cardiopulmonary bypass on remifentanil kinetics in children undergoing atrial septal defect repair. Anesth Analg, 1999,89:904-908.
10Russell D, Royston D, Rees PH, et al. Effect of temperature and cardiopulmonary bypass on the pharmacokinetics of remifentanil. Br J Anaesth,1997,79: 456-459.
